KPI's P&L

LTM

2020

2019

2018

2017

2016

2015

2014

Net sales (SEKm)

204,7

180,9

155,5

96,6

129,3

104,6

61,8

41,0

Sales growth (%)

17,7

16,3

60,9

-25,3

23,6

69,4

50,8

28,8

Gross margin (%)

89,2

89,4

87,4

84,3

87

84,4

84,6

84,4

Operating loss (SEKm)

-85,6

-98,6

-158,1

-174,4

-99,3

-88,7

-53,9

-39,3

1/ LTM refers to Latest Twelve Months (October 2020 - September 2021)

KPI's

Q3 2021

Q2 2021

Q1 2021

Q4 2020

Q3 2020

2020

2019

2018

2017

Net sales (SEKm)

54,9

51,8

44,8

53,2

48,1

180,9

155,5

96,6

129,3

Sales growth (%)

14,1

43,1

3,2

15,1

22,9

16,3

60,9

-25,3

23,6

Gross margin (%)

89,0

89,5

88,6

89,8

91,4

89,4

87,4

84,3

87

Operating loss (SEKm)

-13,3

-25,9

-19,7

-26,7

-19,2

-98,6

-158,1

-174,4

-99,3

Loss for the period (SEKm)

-14,1

-27,0

-20,2

-27,2

-21,2

-101,4

-161,1

-176,4

-128,9

Equity at period end (SEKm)

284,9

359,7

380,1

398,9

425,1

398,9

124,3

278,5

450,8

Net debt at period end (SEKm)

-214,5

-300,3

-328,9

-343,3

-367,3

-343,3

-81,7

-261,5

-434,7

Cash at period end (SEKm)

225,5

309,6

339,0

353,7

377,9

353,7

92,1

261,5

533,4

Earnings per share before and after dilution (SEK)

-0,22

-0,42

-0,32

-0,43

-0,33

-1,72

-3,10

-3,46

-3,24

Income statement (SEKt)

Q3 2021

Q2 2021

Q1 2021

Q4 2020

Q3 2020

2020

2019

2018

2017

Net sales

54 877

51 777

44 829

53 175

48 078

180 860

155 462

96 623

129 301

Cost of sales

-6 051

-5 448

-5 101

-5 418

-4 125

-19 256

-19 587

-15 157

-16 871

Gross profit

48 826

46 329

39 728

47 757

43 953

161 604

135 875

81 466

112 430

Gross margin

89,0%

89,5%

88,6%

89,8%

91,4%

89,4%

87,4%

84,3%

87,0%

Selling expenses

-35 507

-34 090

-31 153

-33 884

-31 982

-123 818

-160 139

-132 211

-92 858

Sales commissions

-10 017

-9 256

-7 869

-8 371

-9 230

-31 598

-22 184

-1 100

0

Research & development expenses

-11 326

-15 031

-12 257

-16 467

-11 654

-57 898

-68 878

-66 064

-60 636

Administrative expenses

-5 401

-13 991

-9 903

-12 647

-11 641

-45 492

-43 280

-58 345

-57 478

Other operating income

1 447

1 187

3 499

1 594

4 173

12 188

10 667

8 530

5 282

Other operating expenses

-1 302

-1 088

-1 721

-4 638

-2 845

-13 547

-10 163

-6 680

-6 025

Operating loss

-13 280

-25 940

-19 676

-26 656

-19 226

-98 561

-158 102

-174 404

-99 285

Net financial items

-519

-32

-338

615

-832

-440

-177

-465

-28 577

Loss before income tax

-13 799

-25 972

-20 014

-26 041

-20 058

-99 001

-158 279

-174 869

-127 862

Income tax

-269

-1 073

-201

-1 124

-1 171

-2 411

-2 781

-1 536

-1 007

Loss for the period

-14 068

-27 045

-20 215

-27 165

-21 229

-101 412

-161 060

-176 405

-128 869

Balance sheet (SEKt)

ASSETS

Sep 30, 21

Jun 30, 21

Mar 31, 21

Dec 31, 20

Dec 31, 19

Dec 31, 18

Dec 31, 17

Intangible assets

8 358

8 523

8 742

8 840

7 679

5 511

5 244

Tangible assets and right-of-use assets

15 242

13 627

14 147

15 003

14 585

3 885

3 099

Other non-current assets

0

0

0

0

951

375

248

Total non-current assets

23 600

22 150

22 889

23 843

23 215

9 771

8 591

Inventories

47 725

45 367

46 681

45 555

39 331

23 681

22 079

Trade receivables

35 717

32 089

28 598

32 108

29 848

18 683

20 678

Other operating receivables

10 139

9 826

6 884

9 975

11 873

12 538

11 969

Cash and cash equivalents

225 497

309 559

338 956

353 737

92 065

261 468

533 367

Total current assets

319 078

396 841

421 119

441 375

173 117

316 370

588 093

TOTAL ASSETS

342 678

418 991

444 008

465 218

196 332

326 141

596 684

EQUITY AND LIABILITIES

Sep 30, 21

Jun 30, 21

Mar 31, 21

Dec 31, 20

Dec 31, 19

Dec 31, 18

Dec 31, 17

Equity

284 921

359 667

380 066

398 899

124 309

278 531

450 786

Leasing debt

5 388

3 920

5 704

5 622

5 703

0

0

Provisions

329

329

329

329

305

289

173

Total non-current liabilities

5 717

4 249

6 033

5 951

6 008

289

173

Leasing debt/current borrowings

5 647

5 297

4 305

4 858

4 682

0

98 620

Trade payables

14 371

11 574

10 253

12 680

13 649

12 472

11 553

Other operating liabilities

32 022

38 204

43 351

42 830

47 684

34 849

35 352

Total current liabilities

52 040

55 075

57 909

60 368

66 015

47 321

145 725

TOTAL EQUITY AND LIABILITIES

342 678

418 991

444 008

465 218

196 332

326 141

596 684

Cash flows (SEKt)

Q3 2021

Q2 2021

Q1 2021

Q4 2020

Q3 2020

2020

2019

2018

2017

Operating loss

-13 280

-25 940

-19 676

-26 656

-19 226

-98 561

-158 102

-174 404

-99 285

Non-cash adjustments

1 070

4 233

-742

8 948

5 090

21 724

17 556

3 194

16 707

Interest received

0

0

0

1

0

5

98

82

3

Interest paid

-57

-60

-3

-3

-735

-6

-36

-868

-11 740

Other financial expenses paid

0

0

0

0

0

0

0

558

0

Income tax paid

133

-363

-309

-1499

-1081

-4 970

-5 210

-2 151

-737

Net cash flows from operating activities before

-12 134

-22 130

-20 730

-19 209

-15 952

-81 808

-145 694

-173 589

-95 052

changes in working capital

Changes in working capital

-8 057

-10 375

6 751

-2 337

-3 066

-18 467

-18 134

1 964

-12 482

Net cash flows from operating activities

-20 191

-32 505

-13 979

-21 546

-19 018

-100 275

-163 828

-171 625

-107 534

Net cash flows from investing activities

-398

-841

-249

-329

-540

-2 658

-4 425

-2 719

-4 688

Net cash flows from financing activities

-63 641

4 232

-955

-1 868

1 977

365 338

-1 816

-98 791

504 833

Total cash flows for the period

-84 230

-29 114

-15 183

-23 743

-17 581

262 405

-170 069

-273 135

392 611

Cash and cash equivalents as at beginning of period

309 559

338 956

353 737

377 877

395 471

92 065

261 468

533 367

141 501

Net exchange difference

168

-243

402

-397

-13

-733

666

1 236

-745

Cash and cash equivalents as at period end

225 497

309 599

338 956

353 737

377 877

353 737

92 065

261 468

533 367

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Bonesupport Holding AB published this content on 04 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2021 07:11:08 UTC.